-
A study group in Greece used 3 consecutive different regimens to achieve a 98% eradication rate among 540 patients not lost to follow-up. The success of each individual regimen was about 70%.
-
A new antiplatelet drug has been approved by the FDA for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention.
-
Hidradenitis suppurativa (HSP) is regarded both in the dermatology and primary care communities as a "heart sink" diagnosis: Patients are generally chronically burdened, we have little successful treatment, the pathophysiology is poorly understood, and the consequences often have an important negative impact on quality of life.
-
-
-
Polypharmacy is the simultaneous use of multiple medications. Many authors have defined polypharmacy as the simultaneous use of at least five or six medications. Others have suggested that polypharmacy should not be determined by the absolute number of medications, but rather the use of even a single medication that is not clearly indicated.
-
Tamoxifen and CYP2D6 inhibitors, FDA Actions, and FDA Warnings.
-
-
Patients who receive proton-pump inhibitors in the hospital are at increased risk for hospital-acquired pneumonia.
-
The combination of a CBC and a BMP can predict death.
